Advertisement

Journal of Gastrointestinal Surgery

, Volume 20, Issue 6, pp 1253–1264 | Cite as

Pharmacological management to prevent ileus in major abdominal surgery: a systematic review and meta-analysis

  • T. M. DrakeEmail author
  • A. E. Ward
Review Article

Abstract

Background

Prolonged ileus is a common complication following gastrointestinal surgery, with an incidence of up to 40 %. Investigations examining pharmacological treatment of ileus have proved largely disappointing; however, recently, several compounds have been shown to have benefited when used as prophylaxis to prevent ileus.

Objective

This review aimed to evaluate the safety and efficacy of compounds which have been recently developed or repurposed to reduce bowel recovery time, thereby preventing ileus.

Data sources

Data were taken from a systematic review of the MEDLINE, EMBASE and Cochrane Library Databases, in addition to manual searching of reference lists up to April 2015. No limits were applied.

Study selection

Only randomized trials were eligible for inclusion.

Interventions

Opioid receptor antagonists, ghrelin receptor agonists and serotonin receptor agonists used for the prevention of postoperative ileus in gastrointestinal surgery.

Main outcome measures

Outcomes of time to first defecation, first flatus and composite bowel recovery endpoints (GI2 and GI3) were used to determine efficacy. Pooled treatment effects were presented as the standard mean difference or as hazard ratios alongside the corresponding 95 % confidence intervals. Risk of bias was assessed using the Cochrane risk of bias framework.

Results

A total of 17 studies were included in the final analysis. The μ-opioid receptor antagonist alvimopan and serotonin receptor agonists appeared to significantly shorten the duration of ileus. The use of Ghrelin receptor agonists did not appear to have any effect in five trials. No publication bias was detected.

Limitations

Most of the trials were poorly reported and of mixed quality. Future studies must focus on the development of a set of core outcomes.

Conclusions

There is evidence to make a strong recommendation for the use of alvimopan in major gastrointestinal surgery to reduce postoperative ileus. Further randomized trials are required to establish whether serotonin receptor agonists are of use. Identifying a low-cost compound to promote bowel recovery following surgery could reduce complications and shorten duration of hospital admissions.

Keywords

Postoperative complications Postoperative care Ileus Digestive system surgery Opioid antagonists Serotonin receptor 

Notes

Acknowledgments

Neither author has any conflicts of interest to declare. This study was unfunded. This work was undertaken by one of the authors (TD) during a period of research funded by the Royal College of Surgeons of Edinburgh and the Pathological Society. Both authors contributed equally in the study conception, analysis and drafting of the final manuscript. Both TD and AW approved the final manuscript version prior to submission.

Compliance with Ethical Standards

Conflict of Interest

TD has received research funding from the Royal College of Surgeons of Edinburgh, The Pathological Society, The Institute of Medical Ethics, The British Medical Association, The Wellcome Trust/Academy of Medical Sciences and The Bowel Disease Research Fund. Neither individual owns stocks and shares in any company related to this article. Neither individual owns any patents related to this article.

Funding

This study was unfunded. The preparation of this manuscript was unfunded. Initial data analyses were undertaken by TD and AW.

References

  1. 1.
    Lubawski J, Saclarides TJ. Postoperative ileus: Strategies for reduction. Ther Clin Risk Manag. 2008;4(5):913–917.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Verma R, Rl N, Verma R, Nelson RL. Prophylactic nasogastric decompression after abdominal surgery (Review) Prophylactic nasogastric decompression after abdominal surgery. 2010;(3). doi: 10.1002/14651858.CD004929.pub3.Copyright.
  3. 3.
    Fitzgerald JEF, Ahmed I. Systematic review and meta-analysis of chewing-gum therapy in the reduction of postoperative paralytic ileus following gastrointestinal surgery. World J Surg. 2009;33(12):2557–2566. doi: 10.1007/s00268-009-0104-5.CrossRefPubMedGoogle Scholar
  4. 4.
    Short V, Herbert G, Perry R, et al. Chewing gum for postoperative recovery of gastrointestinal function. Cochrane Rev. 2014;(2). doi: 10.1002/14651858.CD006506.pub3.Copyright.
  5. 5.
    Carroll J, Alavi K. Pathogenesis and Management of Postoperative Ileus. Clinics. 2009;1(212):47–50. doi: 10.1055/s-0029-1202886.Google Scholar
  6. 6.
    Traut U, Brügger L, Kunz R, et al. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults (Review) Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. 2009;(4):4–6. doi: 10.1002/14651858.CD004930.pub3.Copyright.
  7. 7.
    Smith a J, Nissan a, Lanouette NM, et al. Prokinetic effect of erythromycin after colorectal surgery: randomized, placebo-controlled, double-blind study. Dis Colon Rectum. 2000;43(3):333–337. doi: 10.1007/BF02258298.
  8. 8.
    Jiang D, Zhang Y, Jiang Z, Li ZZ. Intravenous low-dose erythromycin could be an efficacious treatment for acute colonic pseudo-obstrcution (ACPO)/Ogilvie’s syndrome in children. Med Hypotheses. 2008;70(3):706. doi: 10.1016/j.mehy.2007.06.010.CrossRefPubMedGoogle Scholar
  9. 9.
    Lightfoot AJ, Eno M, Kreder KJ, O’Donnell M a., Rao SSC, Williams RD. Treatment of Postoperative Ileus After Bowel Surgery with Low-Dose Intravenous Erythromycin. Urology. 2007;69(4):611–615. doi: 10.1016/j.urology.2006.12.027.CrossRefPubMedGoogle Scholar
  10. 10.
    De Winter BY, Boeckxstaens GE, De Man JG, et al. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats. Gut. 1999;45(5):713–718. doi: 10.1136/gut.45.5.713.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig Dis Sci. 2007;52(9):2241–2248. doi: 10.1007/s10620-007-9783-7.CrossRefPubMedGoogle Scholar
  12. 12.
    Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab. 2006;91(9):3296–3302. doi: 10.1210/jc.2005-2638.CrossRefPubMedGoogle Scholar
  13. 13.
    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, John PA. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions explanation and elaboration -- Liberati et al._ 339 b2700 -- BMJ.PDF. 2009. doi: 10.1136/bmj.b2700.
  14. 14.
    Mary C, Steps SR, Search L, et al. Guidelines for writing systematic reviews.Google Scholar
  15. 15.
    Büchler MW, Seiler CM, Monson JRT, et al. Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008;28(3):312–325. doi: 10.1111/j.1365-2036.2008.03696.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Delaney CP, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, Mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum. 2005;48(6):1114–1129. doi: 10.1007/s10350-005-0035-7.CrossRefPubMedGoogle Scholar
  17. 17.
    Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc. 2006;20(1):64–70. doi: 10.1007/s00464-005-0104-y.CrossRefPubMedGoogle Scholar
  18. 18.
    Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist. Ann Surg. 2004;240(4):728–735. doi: 10.1097/01.sla.0000141158.27977.66.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Taguchi A, Sharma N, Saleem RM, et al. Selective Postoperative Inhibition of Gastrointestinal Opioid Receptors. N Engl J Med. 2001;345(13):935–940.CrossRefPubMedGoogle Scholar
  20. 20.
    Yu CS, Chun HK, Stambler N, et al. Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: Results of two randomized, placebo-controlled phase 3 trials. Dis Colon Rectum. 2011;54(5):570–578. doi: 10.1007/DCR.0b013e3182092bde.CrossRefPubMedGoogle Scholar
  21. 21.
    Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg. 2008;143(11):1098–1105. doi: 10.1001/archsurg.143.11.1098.CrossRefPubMedGoogle Scholar
  22. 22.
    Beck DE, Sweeney WB, McCarter MD. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014;29(12):1527–1534. doi: 10.1007/s00384-014-2030-8.CrossRefPubMedGoogle Scholar
  23. 23.
    Shaw M, Pediconi C, McVey D, et al. Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials. Dis Colon Rectum. 2013;56(7):888–897. doi: 10.1097/DCR.0b013e31829196d0.CrossRefPubMedGoogle Scholar
  24. 24.
    Popescu I, Fleshner PR, Pezzullo JC, Charlton P a., Kosutic G, Senagore AJ. The ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: A randomized, dose-ranging, placebo-controlled clinical trial. Dis Colon Rectum. 2010;53(2):126–134. doi: 10.1007/DCR.0b013e3181b54166.CrossRefPubMedGoogle Scholar
  25. 25.
    Bochicchio G, Charlton P, Pezzullo JC, Kosutic G, Senagore A. Ghrelin agonist TZP-101/ulimorelin accelerates gastrointestinal recovery independently of opioid use and surgery type: Covariate analysis of phase 2 data. World J Surg. 2012;36(1):39–45. doi: 10.1007/s00268-011-1335-9.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Falkén Y, Webb DL, Abraham-Nordling M, Kressner U, Hellström PM, Näslund E. Intravenous ghrelin accelerates postoperative gastric emptying and time to first bowel movement in humans. Neurogastroenterol Motil. 2013;25(6):474–480. doi: 10.1111/nmo.12098.CrossRefPubMedGoogle Scholar
  27. 27.
    Chan DC, Liu YC, Chen CJ, et al. Preventing prolonged post-operative ileus in gastric cancer patients undergoing gastrectomy and intra-peritoneal chemotherapy. World J Gastroenterol. 2005;11(31):4776–4781.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Davidson ED, Hersh T, Brinner R a, Barnett SM, Boyle LP. The effects of metoclopramide on postoperative ileus. A randomized double-blind study. Ann Surg. 1979;190(1):27–30. doi: 10.1097/00000658-197907000-00006.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Jepsen S, Klaerke A, Nielsen PH, Simonsen O. Negative effect of Metoclopramide in postoperative adynamic ileus. A prospective, randomized, double blind study. Br J Surg. 1986;73(4):290–291.CrossRefPubMedGoogle Scholar
  30. 30.
    Narita K, Tsunoda A, Takenaka K, Watanabe M, Nakao K, Kusano M. Effect of mosapride on recovery of intestinal motility after hand-assisted laparoscopic colectomy for carcinoma. Dis Colon Rectum. 2008;51(11):1692–1695. doi: 10.1007/s10350-008-9407-0.CrossRefPubMedGoogle Scholar
  31. 31.
    Toyomasu Y, Mochiki E, Morita H, et al. Mosapride Citrate Improves Postoperative Ileus of Patients with Colectomy. J Gastrointest Surg. 2011;15(8):1361–1367. doi: 10.1007/s11605-011-1567-x.CrossRefPubMedGoogle Scholar
  32. 32.
    Montedori A, Bonacini MI, Casazza G, et al. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study. Trials. 2011;12(1):58. doi: 10.1186/1745-6215-12-58.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Hilton WM, Lotan Y, Parekh DJ, Basler JW, Svatek RS. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: A cost-effectiveness analysis. BJU Int. 2013;111(7):1054–1060. doi: 10.1111/j.1464-410X.2012.11499.x.CrossRefPubMedGoogle Scholar
  34. 34.
    Lee CT, Chang SS, Kamat AM, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: A multicenter randomized placebo-controlled trial. Eur Urol. 2014;66(2):265–272. doi: 10.1016/j.eururo.2014.02.036.CrossRefPubMedGoogle Scholar
  35. 35.
    Karuppiah S, Farrah R. Alvimopan (Entereg) for the Treatment of Postoperative Ileus. 2011. http://www.aafp.org/afp/2011/0415/p978.pdf.
  36. 36.
    Quigley EM. Cisapride: What can we learn from the rise and fall of a prokinetic? J Dig Dis. 2011;12(3):147–156. doi: 10.1111/j.1751-2980.2011.00491.x.CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2016

Authors and Affiliations

  1. 1.Academic Unit of Surgical Oncology, The Medical SchoolUniversity of SheffieldSheffieldUK
  2. 2.Leeds Institute of Cardiovascular and Metabolic MedicineUniversity of LeedsLeedsUK
  3. 3.Sheffield Teaching Hospitals NHS Foundation TrustSheffieldUK

Personalised recommendations